Authorized Generics In Spotlight At Senate Hearing
By Anne Urda · April 11, 2007, 12:00 AM EDT
Despite suffering a defeat in the Schering-Plough case, the Federal Trade Commission intends to continue fighting authorized generics agreements and has vowed to make its crackdown on so-called reverse payments one...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login